Related Experiment Video
Updated: Aug 24, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
Pathophysiology of focal cerebral ischemia: a therapeutic perspective
1Department of Neurology, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, California 94143-0114, USA. wssmith@itsa.ucsf.edu
Abstract:
The pathophysiology of cerebral ischemia is best understood in animal models of stroke. Within minutes of interrupted blood flow, mitochondria are deprived of substrate, which prevents adenosine triphosphate generation and results in membrane depolarization. This leads to increased intracellular calcium and sodium concentration followed by generation of free radicals and initiation of apoptosis. Glutamate release from ischemic neurons contributes to cellular damage. Each step in this complex, interdependent series of events offers a potential point to intervene and prevent neuronal death. Although many human trials in acute stroke therapy have had disappointing results, many promising therapies are in the pipeline, including hypothermia and free-radical inhibitors. Herein, the author discusses the pathophysiology of focal cerebral ischemia as has been revealed in rodent models and reviews the major human trials according to treatment mechanism.
Insights
Animal models reveal cerebral ischemia pathophysiology, detailing mitochondrial dysfunction and apoptosis. Promising stroke therapies targeting these mechanisms are under investigation despite past clinical trial challenges.
Area of Science:
- Neuroscience
- Pathophysiology
- Stroke Research
Background:
- Cerebral ischemia pathophysiology is best understood through animal stroke models.
- Interrupted blood flow rapidly impairs mitochondrial function, ATP generation, and leads to membrane depolarization.
- This cascade involves increased intracellular calcium and sodium, free radical generation, and apoptosis initiation.
Purpose of the Study:
- To discuss the pathophysiology of focal cerebral ischemia.
- To review major human trials in acute stroke therapy based on treatment mechanisms.
Main Methods:
- Utilized rodent models to elucidate the mechanisms of cerebral ischemia.
- Reviewed human clinical trials focusing on therapeutic interventions for acute stroke.
Main Results:
- Identified key steps in ischemic cascade: mitochondrial dysfunction, ion imbalance, oxidative stress, and apoptosis.
- Highlighted glutamate release as a contributor to neuronal damage.
- Noted disappointing results in many human acute stroke therapy trials.
Conclusions:
- Each step in the ischemic cascade presents potential therapeutic intervention points.
- Despite challenges, promising therapies like hypothermia and free-radical inhibitors are in development.
More Related Videos
08:41Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice
Published on: December 29, 2016
05:44Selective and Permanent Occlusion of the Middle Cerebral Artery in Rats: An Experimental Approach for Studying Motor and Spatial Memory Deficits
Published on: March 20, 2026
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cerebral Edema ll: Pathophysiology